SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-14 |
| Reported value | $881,289,158 |
| Positions | 7 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Kymera Therapeutics, Inc. | KYMR | Common Stock | $326,527,526 | 2,847,541 |
| Dyne Therapeutics, Inc. | DYN | Common Stock | $151,030,199 | 6,800,099 |
| Sionna Therapeutics, Inc. | SION | Common Stock | $131,776,532 | 2,995,602 |
| Kailera Therapeutics, Inc. | KLRA | Common Stock | $113,923,342 | 5,171,282 |
| Disc Medicine, Inc. | IRON | Common Stock | $110,724,818 | 1,513,875 |
| Q32 Bio, Inc. | QTTB | Common Stock | $34,615,930 | 2,717,106 |
| Korro Bio, Inc. | KRRO | Common Stock | $12,690,811 | 962,884 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.